
Ask a doctor about a prescription for TELMISARTAN ALTER 40 mg TABLETS
Package Leaflet: Information for the Patient
Telmisartan Alter 40 mg Tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Telmisartan belongs to a class of medications known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body that causes your blood vessels to narrow, increasing your blood pressure. Telmisartan blocks the effect of angiotensin II, so your blood vessels relax and your blood pressure decreases.
Telmisartan Alter is used totreat essential hypertension (high blood pressure). "Essential" means that high blood pressure is not due to any other cause.
High blood pressure, if left untreated, can damage blood vessels in various organs, which can lead, in some cases, to heart attacks, heart failure, or kidney or brain damage. Generally, no symptoms of high blood pressure appear before damage occurs. Therefore, it is essential to regularly check your blood pressure to see if it is within the normal range.
Telmisartan Alter is also used toreduce cardiovascular events (e.g., heart attacks or strokes) in patients at risk because their blood supply to the heart or legs is reduced or blocked, or they have had a stroke or are at high risk of developing diabetes. Your doctor will inform you if you are at high risk of experiencing these events.
Do not take Telmisartan Alter
If your case is any of the above, inform your doctor or pharmacist before taking Telmisartan Alter.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Telmisartan Alter.
Consult your doctor if you are suffering or have ever suffered from any of the following disorders or diseases:
Consult your doctor before taking Telmisartan Alter:
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals. See also the information under the headings "Do not take Telmisartan Alter" and "Warnings and Precautions".
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Telmisartan Alter. Your doctor will decide whether to continue treatment. Do not stop taking Telmisartan Alter on your own.
If you are pregnant, think you may be pregnant, or plan to become pregnant, inform your doctor. Telmisartan is not recommended during the first trimester of pregnancy (the first 3 months) and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby (see the Pregnancy section).
In case of surgery or anesthesia, inform your doctor that you are taking telmisartan.
Telmisartan may be less effective in lowering blood pressure in black patients.
Children and Adolescents
The use of telmisartan is not recommended in children and adolescents up to 18 years of age.
Taking Telmisartan Alter with Other Medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication. Your doctor may need to change the dose of these medications or take other precautions. In some cases, you may need to stop taking one of the medications. This is especially applicable to the following medications when taken with telmisartan:
The effect of telmisartan may be reduced when you use NSAIDs (e.g., aspirin or ibuprofen) or corticosteroids.
Telmisartan may increase the blood pressure-lowering effect of other medications used to treat high blood pressure or medications that may potentially lower blood pressure (e.g., baclofen, amifostine).
Additionally, the decrease in blood pressure may be exacerbated by alcohol, barbiturates, narcotics, or antidepressants. You may notice this effect as dizziness when standing up. You should consult your doctor if you need to adjust the dose of your other medications while taking telmisartan.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
You should inform your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant. Your doctor will usually advise you to stop taking telmisartan before becoming pregnant or as soon as you become pregnant and recommend taking another blood pressure medication instead. Telmisartan is not recommended during the first trimester of pregnancy and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby when administered from that time on.
Breastfeeding
Inform your doctor if you are about to start or are breastfeeding, as telmisartan is not recommended for women during this period. Your doctor may decide to administer a treatment that is more suitable if you want to breastfeed, especially newborns or premature babies.
Driving and Using Machines
There is no information available on the effect of telmisartan on the ability to drive and use machines. Some people may feel dizzy or tired when being treated for high blood pressure. If you feel dizzy or tired, do not drive or use machines.
Telmisartan Alter Contains Sorbitol
This medication contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the instructions for administration of this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose of telmisartan is one tablet per day. Try to take the tablet at the same time each day. You can take telmisartan with or without food. The tablets should be swallowed with a little water or other non-alcoholic beverage. It is essential that you take telmisartan every day until your doctor tells you otherwise. If you think the effect of telmisartan is too strong or too weak, tell your doctor or pharmacist.
For the treatment of high blood pressure, the usual dose of telmisartan for most patients is one 40 mg tablet once a day, to control blood pressure over 24 hours. However, your doctor may sometimes recommend a lower dose of 20 mg or a higher dose of 80 mg. Telmisartan can also be used in combination with diuretics, such as hydrochlorothiazide, which has been shown to have an additive blood pressure-lowering effect with telmisartan.
For the reduction of cardiovascular events, the usual daily dose of telmisartan is one 80 mg tablet. At the start of preventive treatment with telmisartan 80 mg, blood pressure should be monitored frequently.
If your liver is not functioning correctly, the usual dose should not exceed 40 mg once a day.
If You Take More Telmisartan Alter Than You Should
If you accidentally take too many tablets, consult your doctor, pharmacist, or the emergency department of the nearest hospital or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If You Forget to Take Telmisartan Alter
If you forget to take a dose, do not worry. Take it as soon as you remember and continue as before.
If you do not take your tablet one day, take your normal dose the next day. Do not take a double dose to make up for forgotten doses.
If you have any doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Some side effects may be serious and require immediate medical attention:
If you experience any of the following symptoms, you should visit your doctor immediately:
Sepsis* (often called "blood infection," a severe infection that involves an inflammatory reaction of the entire body), rapid swelling of the skin and mucous membranes (angioedema); these side effects are rare (may affect up to 1 in 1,000 people) but are extremely serious, and patients should stop taking the medication and visit their doctor immediately. If these side effects are not treated, they can be fatal.
Possible Side Effects of Telmisartan Alter:
Common side effects (may affect up to 1 in 10 people):
Low blood pressure (hypotension) in users treated for cardiovascular event reduction.
Uncommon side effects (may affect up to 1 in 100 people):
Urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), decreased red blood cells (anemia), high potassium levels, difficulty falling asleep (insomnia), feeling of sadness (depression), fainting (syncope), feeling of losing balance (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness when standing up (orthostatic hypotension), difficulty breathing, cough, abdominal pain, diarrhea, abdominal discomfort, abdominal distension, vomiting, itching, increased sweating, drug rash (skin reaction to medications), back pain, muscle cramps, muscle pain (myalgia), kidney failure including acute kidney failure, chest pain, symptoms of weakness, and high creatinine levels in the blood.
Rare side effects (may affect up to 1 in 1,000 people):
Sepsis* (often called "blood infection," a severe infection that involves an inflammatory reaction of the entire body and can cause death), increased certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling of anxiety, drowsiness, vision changes, increased heart rate (tachycardia), dry mouth, stomach upset, taste changes (dysgeusia), abnormal liver function (Japanese patients show a greater tendency to experience this side effect), sudden swelling of the skin and mucous membranes that can cause death (angioedema, including fatal outcome), eczema (a skin condition), skin redness, hives (urticaria), severe drug rash, joint pain (arthralgia), limb pain, tendon pain, pseudogripal illness, decrease in hemoglobin (a blood protein), increased blood levels of uric acid, increased liver enzymes or creatine phosphokinase in the blood.
Very rare side effects (may affect up to 1 in 10,000 people):
Progressive scarring of lung tissue (interstitial lung disease)**.
** Cases of progressive scarring of lung tissue have been reported during treatment with telmisartan. However, it is unknown whether telmisartan was the cause.
Frequency not known (cannot be estimated from available data):
Intestinal angioedema: inflammation in the intestine with symptoms such as abdominal pain, nausea, vomiting, and diarrhea has been reported after the use of similar products.
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature. Store in the original packaging to protect it from moisture. Remove your telmisartan tablet from the blister pack just before taking it.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Telmisartan Alter
Appearance of the Product and Package Contents
Telmisartan Alter 40 mg are white or slightly beige, round, biconvex tablets without a score.
Telmisartan Alter is available in blister packs containing 28 tablets.
Marketing Authorization Holder and Manufacturer
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Date of Last Revision of this Package Leaflet: February 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of TELMISARTAN ALTER 40 mg TABLETS in November, 2025 is around 9.99 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TELMISARTAN ALTER 40 mg TABLETS – subject to medical assessment and local rules.